Comparison of chitosan microsphere versus O-carboxymethyl chitosan microsphere for drug delivery systems
Authors:
- 1 February 2017
- journal article
- research article
- Published by SAGE Publications in Journal of Bioactive and Compatible Polymers
- Vol. 32 (5) , 469-486
Abstract
The development of controlled drug delivery systems for bone regeneration, especially microspheres, has become a research hotspot in recent years. Chitosan and its derivative O-carboxymethyl chitosan have been considered to be an effective way for controlled drug delivery due to their nontoxicity and biodegradability. Currently, most of the studies have researched on synthesizing and characterizing chitosan and O-carboxymethyl chitosan. However, few studies have focused on the differences between chitosan microspheres and O-carboxymethyl chitosan microspheres directly. In this study, chitosan and O-carboxymethyl chitosan microspheres were developed by water-in-oil emulsification cross-linking method using vanillin as the cross-linking agent, and then their physicochemical properties were evaluated by Fourier transform infrared spectroscopy, scanning electron microscopy, and in vitro release testing. The results showed that O-carboxymethyl chitosan was successfully modified by adding carboxymethyl group at the chitosan C6 position.The particle size of chitosan microspheres (50–90 µm) was significantly larger than that of O-carboxymethyl chitosan microspheres (10–50 µm), and the drug release profile of O-carboxymethyl chitosan microspheres showed larger initial burst release within the first day and sustained release at the fourth day, while chitosan microspheres showed sustained release at the seventh day. In addition, Cell Counting Kit-8 assay showed that MC3T3-E1 proliferated well and highly expressed the alkaline phosphatase marker protein on both chitosan and O-carboxymethyl chitosan microspheres. Overall, both chitosan and O-carboxymethyl chitosan microspheres showed good biocompatibility, and chitosan microspheres were superior to O-carboxymethyl chitosan microspheres. Moreover, the different drug release rates suggest that chitosan and O-carboxymethyl chitosan microspheres have the potential to be used for the repair of different bone defects.Keywords
Funding Information
- the National Key Research and Development Program (2016YFC1100704)
This publication has 46 references indexed in Scilit:
- A versatile platform of magnetic microspheres loaded with dual-anticancer drugs for drug releaseMaterials Chemistry and Physics, 2016
- Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanismInternational Journal of Pharmaceutics, 2016
- A novel study on the mechanisms of drug release in PLGA-mPEG microspheres with fluorescent drugJournal of Biomaterials Science, Polymer Edition, 2016
- The scope and sequence of growth factor delivery for vascularized bone tissue regenerationJournal of Controlled Release, 2015
- Fabrication and characterization of carboxymethyl chitosan/poly(vinyl alcohol) hydrogels containing alginate microspheres for protein deliveryJournal of Bioactive and Compatible Polymers, 2015
- Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclustersBiomaterials, 2015
- Liposomal drug delivery systems: From concept to clinical applicationsAdvanced Drug Delivery Reviews, 2013
- In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineeringBiomaterials, 2006
- Polymer microspheres for controlled drug releaseInternational Journal of Pharmaceutics, 2004
- Bioadhesive microspheres as a controlled drug delivery systemInternational Journal of Pharmaceutics, 2003